Indian Pharma stocks were sulking on Tuesday after brokerage firm Macquarie issued a double-downgrade on Aurobindo Pharma and a downgrade on Dr. Reddy’s Laboratories and also revised the price targets sharply lower for five drugmakers.
Indian Pharma stocks were sulking on Tuesday after brokerage firm Macquarie issued a double-downgrade on Aurobindo Pharma and a downgrade on Dr. Reddy’s Laboratories and also revised the price targets sharply lower for five drugmakers.